The Science Advisory Board

President Biden launches $50M initiative to improve cancer outcomes in low-income areas

The Biden-Harris administration on Monday awarded $50 million to launch the Persistent Poverty Initiativ...

3D cellular models identify potential drug target for preventing Alzheimer’s

A 3D cellular model has shown that mutations affec...

Gene mutations linked to drug-resistant liver cancer

Certain gene mutations could serve as markers to hel...

Potential treatment for rare autoimmune disorder adapted from CAR-T therapy in study

Evidence from a small-scale clinical trial suggest...

FDA approves first gene therapy for treatment of certain patients with Duchenne muscular dystrophy

The U.S. Food and Drug Administration (FDA) on Thursda...

Cancer & Disease Research

Lupus pill moves to clinical trial in humans after success in mice
August 22, 2022 -- Scientists at this week’s fall meeting of the American Chemical Society report they have begun phase II clinical trials of an oral pill containing a compound that in mice, not only prevented lupus-like symptoms, but also reversed signs of organ damage caused by the disease and prevented death. Read More

Boosting neuron production offers viable treatment strategy for Alzheimer’s: mice study
August 22, 2022 -- A new study from University of Illinois Chicago researchers shows that boosting neurogenesis, the process by which new neurons are formed in the brain, increases the number of newly formed neurons involved in storing and retrieving memories in the hippocampus of mice with Alzheimer’s disease. Read More